Simplifying Global Compliance
Side-by-Side Industry-Academic Partnerships Are Wave of Future
Clinical Trials Advisor
To meet the dual challenges of drug discovery — developing new compounds faster and at less cost, drugmakers should consider forming more integrated partnerships where company staff and academic scientists work side-by-side, one expert suggests.
To View This Article:
Subscribe To Clinical Trials Advisor
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing